Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
Erstveröffentlichung
2018
Wissenschaftlicher Artikel
Published in
Circulation ; 137 (2018), 9. - S. 989-991. - ISSN 0009-7322. - eISSN 1524-4539